MAKO Surgical Corp (MAKO)

Name: MAKO Surgical Corp (MAKO) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: MAKO Surgical Corp (MAKO)

Stock Card

$10.92

$-0.15 (-1.36%)

As on 26-Aug-2026 16:00EDT

Market cap

$923 Mln

Revenue (TTM)

$208 Mln

P/E Ratio

17.9

P/B Ratio

4.8

Div. Yield

0 %

MAKO Surgical Corp (MAKO) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 10.77 High: 11.00

52 Week Range

Low: 4.35 High: 11.09

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

8.8
Debt to Equity

0
Book Value

$--
EPS

$0.6
Face value

--
Shares outstanding

87,605,909

Years Aggregate

CFO

$--

EBITDA

$--

Net Profit

$--

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
MAKO Surgical Corp (MAKO)	88.3	54.2	34.6	151.0	122.6	32.2	17.9
BSE Sensex^*	-9.1	1.1	1.2	-4.8	5.8	6.6	10.7
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Aug-2026 | *As on 27-Aug-2026 | #As on 26-Oct-2023

The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
MAKO Surgical Corp (MAKO)	10.9	923.4	207.6	52.2	41.3	30.6	17.9	4.8
Curanex Pharmaceuticals Inc (CURX)	4.6	7.4	0.0	-10.5	--	-130.8	--	1.7
Lineage, Inc. (LINE)	40.6	10,433.6	5,371.0	-169.0	8.0	-1.8	--	1.2
Republic Airways Holdings Inc (RJET)	18.6	877.9	1,653.3	49.0	9.7	3.6	12.3	0.6
Viamet Pharmaceuticals Corp (VMET)	10.4	1,154.7	73.3	36.7	71.1	11.7	29.5	2.9

Shareholding Pattern

View Details

About MAKO Surgical Corp (MAKO)

Mako Mining Corp. engages in mineral exploration and exploitation activities in Nicaragua, the United States, and Guyana. The company explores for gold and silver deposits. Its primary asset is its 100%-owned San Albino mine comprising the San Albino... and the Las Conchitas gold deposits, which consist of five mineral concessions covering an area of approximately 22,422 hectares located within the San Albino-Murra Property in Nueva Segovia, Nicaragua. The company was formerly known as Golden Reign Resources Ltd. and changed its name to Mako Mining Corp. in November 2018. Mako Mining Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Read more

CEO & Director

Mr. Akiba Jacob-Issachar Leisman
CFO & Corporate Secretary

Mr. Ezequiel Sirotinsky
Headquarters

Vancouver, BC
Website

https://www.makominingcorp.com

FAQs for MAKO Surgical Corp (MAKO)

What is the current share price of MAKO Surgical Corp (MAKO) Today?

The share price of MAKO Surgical Corp (MAKO) is $10.92 (NASDAQ) as of 26-Aug-2026 16:00 EDT. MAKO Surgical Corp (MAKO) has given a return of 122.6% in the last 3 years.

What is the current PB & PE ratio of MAKO Surgical Corp (MAKO)?

The P/E ratio of MAKO Surgical Corp (MAKO) is 17.86 times as on 21-Aug-2026.
The P/B ratio of MAKO Surgical Corp (MAKO) is 4.83 times as on 21-Aug-2026, a 179 premium to its peers’ median range of 1.73 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	15.37	3.44
2024	9.14	2.28
2023	--	--
2022	--	--
2025	15.37	3.44

What is the 52 Week High and Low of MAKO Surgical Corp (MAKO)?

The 52-week high and low of MAKO Surgical Corp (MAKO) are Rs 11.09 and Rs 4.35 as of 27-Aug-2026.

What is the market cap of MAKO Surgical Corp (MAKO)?

MAKO Surgical Corp (MAKO) has a market capitalisation of $ 923 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in MAKO Surgical Corp (MAKO)?

Before investing in MAKO Surgical Corp (MAKO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.